How to Check Amanta Healthcare IPO Allotment Status?

Amanta Healthcare Limited is a pharmaceutical company specializing in development, manufacturing, and marketing of diverse sterile liquid products, specifically parenteral products packaged in plastic containers utilizing Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies, incorporated in December 1994. The company operates with 1,718 employees as of March 31, 2025, manufacturing over 45 generic products including fluid therapy formulations, IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, first-aid products, and eye lubricants while marketing through 320 distributors and stockists domestically and exporting to 21 countries with products registered in 19 countries across Africa, Latin America, UK, and beyond.

The Amanta Healthcare IPO came with a total issue size of ₹126.00 crore, comprising entirely a fresh issue of 1.00 crore shares aggregating to ₹126.00 crore. The IPO opened on September 1, 2025, and closed on September 3, 2025. The allotment for the Amanta Healthcare IPO is expected to be finalized on Thursday, September 4, 2025. The Amanta Healthcare IPO share price band was set at ₹120 to ₹126 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Registrar: Visit the MUFG Intime India Pvt.Ltd. website 

BSE SME: BSE SME IPO Allotment Status Page

Amanta Healthcare IPO Subscription Status

Amanta Healthcare IPO received exceptional investor interest, being subscribed 82.57 times overall. The subscription showed outstanding confidence across categories in the Amanta Healthcare IPO stock price potential. Here is a category-wise breakdown of the subscription as of 4:59:35 PM on September 3, 2025:

• Non-Institutional Investors (NII): 209.39 times.
• QIB Category: 35.86 times.

Amanta Healthcare IPO Share Price and Investment Details

The Amanta Healthcare IPO stock price band was set at ₹120 to ₹126 per share with a minimum lot size of 119 shares. The minimum investment required for retail investors was ₹14,994 for 1 lot (119 shares). The issue included up to 30,00,000 shares allocated to anchor investors raising ₹37.80 crore. Given the exceptional subscription response of 82.57 times overall, with QIB category showing strong response at 35.86 times and NII demonstrating extraordinary response at 209.39 times, the Amanta Healthcare IPO share price is expected to list with exceptional premium.

Utilisation of IPO Proceeds

The funds raised through the IPO will be utilised as follows:

• Funding capital expenditure for civil construction and equipment purchase for new SteriPort manufacturing line at Hariyala, Kheda, Gujarat: ₹70.00 crore.
• Funding capital expenditure for civil construction and equipment purchase for new SVP manufacturing line at Hariyala, Kheda, Gujarat: ₹30.13 crore.
• General corporate purposes: Remaining amount.

Business Overview

Amanta Healthcare Limited is a well-established pharmaceutical manufacturer with large manufacturing capabilities and wide domestic and international marketing network, specializing in sterile liquid pharmaceutical products through advanced ABFS and ISBM technologies while serving diverse markets.